<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FT932-12382</title>
	</head>
	<body>
		<main>
			<p>930428 FT  28 APR 93 / London Stock Exchange: Drug issues busy Pharmaceutical issues moved sharply higher in late afternoon trading following a surge of buying in New York yesterday. London dealers of internationally traded stocks said the market was enlivened by suggestions that the proposed US reforms would be watered down. Dealers said there had been suggestions that the reforms would be delayed. They added that any delays in the impending health service review which has formed one of the main planks of the Clinton administration made it more likely that changes would be watered down. There was further support from a Pounds 125m programme trade, said to have been carried out by Goldman Sachs and featuring drug stocks heavily. Glaxo advanced 17 to 594p and SmithKline Beecham added 14 1/2 at 460 1/2p.</p>
		</main>
</body></html>
            